“Before [onco-dermatology] was created, skin toxicities, among other things, were one of the most common reasons that cancer-related therapies were stopped,” Allireza Alloo, MD, said in a recent interview with Cancer Network.
As patients…
An Oncodermatologist’s Perspective on Dermatological Toxicities in Breast Cancer
